Cardlytics, Inc.CDLXNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank60
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-28.39%
↑ 24% vs avg
Percentile
P60
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-37.48%
Historical baseline
PeriodValueYoY Change
TTM-28.39%+48.2%
2024-54.81%-71.2%
2023-32.02%+77.3%
2022-140.82%-326.4%
2021-33.02%-51.3%
2020-21.82%-280.7%
2019-5.73%+81.2%
2018-30.51%-374.9%
2017-6.42%+69.8%
2016-21.28%-